Skip to main content

Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens.

Publication ,  Journal Article
Swanson, O; Martin Beem, JS; Rhodes, B; Wang, A; Barr, M; Chen, H; Parks, R; Saunders, KO; Haynes, BF; Wiehe, K; Azoitei, ML
Published in: PLoS Pathog
May 2023

A major goal for the development of vaccines against rapidly mutating viruses, such as influenza or HIV, is to elicit antibodies with broad neutralization capacity. However, B cell precursors capable of maturing into broadly neutralizing antibodies (bnAbs) can be rare in the immune repertoire. Due to the stochastic nature of B cell receptor (BCR) rearrangement, a limited number of third heavy chain complementary determining region (CDRH3) sequences are identical between different individuals. Thus, in order to successfully engage broadly neutralizing antibody precursors that rely on their CDRH3 loop for antigen recognition, immunogens must be able to tolerate sequence diversity in the B cell receptor repertoire across an entire vaccinated population. Here, we present a combined experimental and computational approach to identify BCRs in the human repertoire with CDRH3 loops predicted to be engaged by a target immunogen. For a given antibody/antigen pair, deep mutational scanning was first used to measure the effect of CDRH3 loop substitution on binding. BCR sequences, isolated experimentally or generated in silico, were subsequently evaluated to identify CDRH3 loops expected to be bound by the candidate immunogen. We applied this method to characterize two HIV-1 germline-targeting immunogens and found differences in the frequencies with which they are expected to engage target B cells, thus illustrating how this approach can be used to evaluate candidate immunogens towards B cell precursors engagement and to inform immunogen optimization strategies for more effective vaccine design.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

PLoS Pathog

DOI

EISSN

1553-7374

Publication Date

May 2023

Volume

19

Issue

5

Start / End Page

e1011401

Location

United States

Related Subject Headings

  • Virology
  • Receptors, Antigen, B-Cell
  • Humans
  • HIV-1
  • HIV Infections
  • HIV Antibodies
  • Broadly Neutralizing Antibodies
  • B-Lymphocytes
  • Antibodies, Neutralizing
  • AIDS Vaccines
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Swanson, O., Martin Beem, J. S., Rhodes, B., Wang, A., Barr, M., Chen, H., … Azoitei, M. L. (2023). Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens. PLoS Pathog, 19(5), e1011401. https://doi.org/10.1371/journal.ppat.1011401
Swanson, Olivia, Joshua S. Martin Beem, Brianna Rhodes, Avivah Wang, Maggie Barr, Haiyan Chen, Robert Parks, et al. “Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens.PLoS Pathog 19, no. 5 (May 2023): e1011401. https://doi.org/10.1371/journal.ppat.1011401.
Swanson O, Martin Beem JS, Rhodes B, Wang A, Barr M, Chen H, et al. Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens. PLoS Pathog. 2023 May;19(5):e1011401.
Swanson, Olivia, et al. “Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens.PLoS Pathog, vol. 19, no. 5, May 2023, p. e1011401. Pubmed, doi:10.1371/journal.ppat.1011401.
Swanson O, Martin Beem JS, Rhodes B, Wang A, Barr M, Chen H, Parks R, Saunders KO, Haynes BF, Wiehe K, Azoitei ML. Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens. PLoS Pathog. 2023 May;19(5):e1011401.

Published In

PLoS Pathog

DOI

EISSN

1553-7374

Publication Date

May 2023

Volume

19

Issue

5

Start / End Page

e1011401

Location

United States

Related Subject Headings

  • Virology
  • Receptors, Antigen, B-Cell
  • Humans
  • HIV-1
  • HIV Infections
  • HIV Antibodies
  • Broadly Neutralizing Antibodies
  • B-Lymphocytes
  • Antibodies, Neutralizing
  • AIDS Vaccines